Clinical trialNCT05965752CompletedInterventional

RECOVER-NEURO: Platform Protocol to Measure the Effects of Cognitive Dysfunction Interventions on Long COVID Symptoms

SponsorDuke UniversityEnrollment328Long COVIDLong COVID-19Long COVID19

View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

This platform protocol is designed to be flexible so that it is suitable for a wide range of settings within health care systems, for remote settings, and in community settings where it can be integrated into COVID-19 programs and subsequent treatment plans. This protocol is a prospective, multi-center, multi-arm, randomized, controlled platform trial evaluating potential interventions for PASC-mediated cognitive dysfunction. The hypothesis is that PASC associated dysfunction in cognitive domains, such as executive function and attention, may be improved by interventions that selectively focus on enhancing those domains.

clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

Daniel Laskowitz, MD MHS
Duke University
Study Chair
clinicaltrials.gov ↗
Kanecia Zimmerman, MD PhD
Duke University
Study Chair
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

24 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States

Banner University Medical Center Phoenix
Phoenix, Arizona, United States
Banner University Medical Center- Tucson
Tucson, Arizona, United States
Ronald Reagan Ucla Medical Center
Los Angeles, California, United States
Stanford University
Stanford, California, United States
Lundquist Institute for Biomedical Innovation at Harbor-Ucla Medical Center
Torrance, California, United States
University of Colorado Anschutz Medical Campus
Aurora, Colorado, United States
University of Florida College of Medicine Jacksonville
Jacksonville, Florida, United States
Rush University Medical Center
Chicago, Illinois, United States
Osf Healthcare
Peoria, Illinois, United States
North Shore University Health System/evanston Hospital
Skokie, Illinois, United States
University of Kansas Medical Center
Kansas City, Kansas, United States
Jadestone Clinical Research
Silver Spring, Maryland, United States
Beth Israel Daeconess Medical Center
Boston, Massachusetts, United States
Boston Medical Center
Boston, Massachusetts, United States
Dartmouth-Hitchcock Medical Center
Lebanon, New Hampshire, United States
Nyu Langone Health/brooklyn Hospital
Brooklyn, New York, United States
Icahn School of Medicine at Mount Sinai
New York, New York, United States
Case Western Reserve University
Cleveland, Ohio, United States
University of Texas Health Science Center at Houston
Houston, Texas, United States
University of Texas Health Science Center at San Antonio
San Antonio, Texas, United States
University of Utah Hospitals and Clinics
Salt Lake City, Utah, United States
University of Vermont
Burlington, Vermont, United States
University of Washington
Seattle, Washington, United States
West Virginia Clinical and Translational Science Institute
Morgantown, West Virginia, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 1 Sept 2023
Primary completion: 10 Jun 2024
Completion: 10 Jun 2024
Last update posted: 18 Jul 2025
Registered enrollment: 328
Registry id: NCT05965752

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.